SCHEMBL3413571

SCHEMBL3413571

C1=CC(C=Cc2ccccc2)(C=Cc2ccccc2)CC=C1c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CHAT P28329 1/20 0.31
GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2130582 0.87 APP (0.34) TDP1SMN1; SMN2L3MBTL1
SCHEMBL10495369 0.83 ALDH1A1 (0.42) TDP1NPC1SMN1; SMN2L3MBTL1
SCHEMBL601431 0.83 TRPM8 (0.34) NPC1RAB9ASMN1; SMN2
SCHEMBL3205762 0.80 CHAT (0.34) MAOBTDP1CHATGLA
SCHEMBL7772222 0.79 ALDH1A1 (0.31)
SCHEMBL2353519 0.79 ALDH1A1 (0.31) NPC1
SCHEMBL16416650 0.79 NFE2L2 (0.47) TDP1NPC1RAB9AL3MBTL1
SCHEMBL17706824 0.78 GRIA1 (0.31)
SCHEMBL3172989 0.78 KIF11 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1GLA
SCHEMBL5703386 0.77 TDP1 (0.33) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1610954-B1 METHOD FOR RECORDING INFORMATION IN LUMINESCENT COMPOSITIONS AND USES THEREOF IN ARTICLES OF MANUFACTURE AMERICAN DYE SOURCE INC (CA) 2010-11-17 EP claimed
US-20070258912-A1 Use of Fluorescent Whitening Agents as Antimicrobials CIBA SPECIALTY CHEMICALS CORP. 2007-11-08 US claimed
EP-1776086-A2 USE OF FLUORESCENT WHITENING AGENTS AS ANTIMICROBIALS Ciba Specialty Chemicals Holding Inc. (CH) 2007-04-25 EP claimed
WO-2006015959-A2 USE OF FLUORESCENT WHITENING AGENTS AS ANTIMICROBIALS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-02-16 WO claimed
EP-3015539-B1 LIQUID DETERGENT COMPOSITION KAO CORP SA (ES) 2018-05-02 EP disclosed
US-9611447-B2 Liquid detergent composition comprising an ethoxylated glycerol compound KAO CORPORATION, S.A. (ES) 2017-04-04 US disclosed
EP-2687586-B1 Use of defined cyclohexenones as a means for the additive reinforcement of a smell impression and composition of aromas and/or tastes SYMRISE AG (DE) 2016-11-23 EP disclosed
US-20160130530-A1 LIQUID DETERGENT COMPOSITION KAO CORPORATION, S.A. (ES) 2016-05-12 US disclosed
EP-3015539-A1 LIQUID DETERGENT COMPOSITION KAO CORPORATION, S.A. (ES) 2016-05-04 EP disclosed
WO-2014207286-A1 LIQUID DETERGENT COMPOSITION KAO CORPORATION, S.A. (ES) 2014-12-31 WO disclosed
US-20140023770-A1 Use Of Defined Cyclohexenones As Agents For The Superadditive Enhancement Of An Olfactory Impression And Fragrance And/Or Flavor Material Composition SYMRISE AG (DE) 2014-01-23 US disclosed
EP-2687586-A1 Use of defined cyclohexenones as a means for the additive reinforcement of a smell impression and composition of aromas and/or tastes Symrise AG (DE) 2014-01-22 EP disclosed
WO-2006015959-A2 USE OF FLUORESCENT WHITENING AGENTS AS ANTIMICROBIALS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-02-16 WO disclosed
EP-1419298-A1 METHOD FOR PRODUCTION OF COATED PAPER WITH EXTREME WHITENESS BASF AKTIENGESELLSCHAFT (DE) 2004-05-19 EP disclosed
WO-2003016624-A1 METHOD FOR PRODUCTION OF COATED PAPER WITH EXTREME WHITENESS BASF AKTIENGESELLSCHAFT (DE) 2003-02-27 WO disclosed
EP-0493961-B1 Method of storing information XEROX CORP (US) 1997-03-05 EP disclosed
US-5301044-A Marking material containing a taggant, and method of producing an image XEROX CORPORATION (US) 1994-04-05 US disclosed
US-5225900-A METHOD OF STORING INFORMATION WITHIN A REPRODUCTION SYSTEM XEROX CORPORATION (US) 1993-07-06 US disclosed
EP-0493961-A2 Method of storing information XEROX CORPORATION (US) 1992-07-08 EP disclosed
EP-0064953-B1 STILBENE DERIVATIVES CIBA-GEIGY AG (CH) 1984-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258912-A1 Use of Fluorescent Whitening Agents as Antimicrobials CUTA, CAT, LPO MAOB 266/4885TDP1 1725/4885NPC1 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.